DM
Delphi Management Partners VIII, L.L.C.
Concentrated strategyLong-term holderQuality / disciplined sizing
Total reported value
$138.5M
Reporting period: 2021-09-30 · Number of holdings: 4
Delphi Management Partners VIII, L.L.C. disclosed 4 holdings in its latest 13F filing for the period ending 2021-09-30, with total reported value of $138.5M and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 100
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 8
- Sizing Uniformity
- 83.61
Recent moves
No holding changes this quarter
Holdings Map
New buyAddUnchangedTrim
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | TNDM | Tandem Diabetes Care INC | Stock-Other | 86.22% | — | — | |
| 2 | KPTIEUR | Karyopharm Therapeutics INC | Stock-Other | 9.51% | — | — | |
| 3 | CALAEUR | Calithera Biosciences INC | Stock-Other | 3.82% | — | — | |
| 4 | MREO | Mereo Biopharma Group Pl-adr | Stock-Other | 0.45% | — | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
FAQ
What is Delphi Management Partners VIII, L.L.C. and what type of investor is it?
Delphi Management Partners VIII, L.L.C. is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2021-09-30), the firm manages a tracked equity portfolio valued at approximately $138.5M, spread across 4 disclosed positions.
What are Delphi Management Partners VIII, L.L.C.'s largest equity positions?
Based on the latest 13F filing, Delphi Management Partners VIII, L.L.C.'s top holdings by market value are:
1. Tandem Diabetes Care INC (TNDM) — $119.4M (86.2%)
2. Karyopharm Therapeutics INC (KPTIEUR) — $13.2M (9.5%)
3. Calithera Biosciences INC (CALAEUR) — $5.3M (3.8%)
4. Mereo Biopharma Group Pl-adr (MREO) — $621.0K (0.5%)
What changes did Delphi Management Partners VIII, L.L.C. make in its most recent portfolio filing?
No notable portfolio changes were recorded for Delphi Management Partners VIII, L.L.C. in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Delphi Management Partners VIII, L.L.C. focus on?
Sector breakdown data is not yet available for Delphi Management Partners VIII, L.L.C.. Check back after the next 13F processing cycle.